127 related articles for article (PubMed ID: 35405037)
1. Screening prolyl hydroxylase domain 2 inhibitory activity of traditional Chinese medicine by CZE-UV.
Zhang Y; Zhao M; Wang CB; Wang Y; Nsanzamahoro S; Zhu LL; Wang WF; Yang JL
Electrophoresis; 2022 Aug; 43(15):1601-1610. PubMed ID: 35405037
[TBL] [Abstract][Full Text] [Related]
2. The novel prolyl hydroxylase-2 inhibitor caffeic acid upregulates hypoxia inducible factor and protects against hypoxia.
Guo Z; Yang Y; Li L; Zhao Q; Li Y; Liu Z; Hao L; Guo B; Diao A
Eur J Pharmacol; 2022 Nov; 934():175307. PubMed ID: 36191632
[TBL] [Abstract][Full Text] [Related]
3. Screening of prolyl hydroxylase 2 inhibitors based on quantitative strategy of peptides.
Zhang Y; Nsanzamahoro S; Wang CB; Wang WF; Yang JL
J Chromatogr A; 2022 Aug; 1679():463411. PubMed ID: 35973337
[TBL] [Abstract][Full Text] [Related]
4. Rapid evaluation of PHD2 inhibitory activity of natural products based on capillary electrophoresis online stacking strategy.
Zhang Y; Sang CY; Wang XR; Wang CB; Meng XH; Wang WF; Yang JL
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Apr; 1236():124064. PubMed ID: 38430605
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.
Han WQ; Zhu Q; Hu J; Li PL; Zhang F; Li N
Biochim Biophys Acta; 2013 Jun; 1833(6):1454-62. PubMed ID: 23466866
[TBL] [Abstract][Full Text] [Related]
6. Prolyl hydroxylase 2 deficiency limits proliferation of vascular smooth muscle cells by hypoxia-inducible factor-1{alpha}-dependent mechanisms.
Schultz K; Murthy V; Tatro JB; Beasley D
Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L921-7. PubMed ID: 19304911
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor prolyl-hydroxylase 2 senses high-salt intake to increase hypoxia inducible factor 1alpha levels in the renal medulla.
Wang Z; Zhu Q; Xia M; Li PL; Hinton SJ; Li N
Hypertension; 2010 May; 55(5):1129-36. PubMed ID: 20308610
[TBL] [Abstract][Full Text] [Related]
8. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydropyridin-4-ylpicolinoylglycines as novel and orally active prolyl hydroxylase 2 (PHD2) inhibitors for the treatment of renal anemia.
Su K; Li Z; Zhang L; Fang S; Mao M; Sun Z; Zhang X
Eur J Med Chem; 2022 Aug; 238():114479. PubMed ID: 35675755
[TBL] [Abstract][Full Text] [Related]
10. Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy transfer-based assay technology.
Dao JH; Kurzeja RJ; Morachis JM; Veith H; Lewis J; Yu V; Tegley CM; Tagari P
Anal Biochem; 2009 Jan; 384(2):213-23. PubMed ID: 18952043
[TBL] [Abstract][Full Text] [Related]
11. Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH).
Flagg SC; Martin CB; Taabazuing CY; Holmes BE; Knapp MJ
J Inorg Biochem; 2012 Aug; 113():25-30. PubMed ID: 22687491
[TBL] [Abstract][Full Text] [Related]
12. Production of functional recombinant prolyl hydroxylase-2 enzyme in insect cells for small molecule inhibitor screening studies.
Guo Z; Zi J; Hao Y; Li Y; Liu Z; Zhao Q; Hao L; Diao A
Protein Expr Purif; 2022 Jun; 194():106073. PubMed ID: 35192944
[TBL] [Abstract][Full Text] [Related]
13. Substrate preference of the HIF-prolyl hydroxylase-2 (PHD2) and substrate-induced conformational change.
Pektas S; Knapp MJ
J Inorg Biochem; 2013 Sep; 126():55-60. PubMed ID: 23787140
[TBL] [Abstract][Full Text] [Related]
14. Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury.
Zhao Y; Zeng H; Liu B; He X; Chen JX
Am J Physiol Renal Physiol; 2020 Aug; 319(2):F345-F357. PubMed ID: 32715763
[TBL] [Abstract][Full Text] [Related]
15. Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia.
Kunze R; Zhou W; Veltkamp R; Wielockx B; Breier G; Marti HH
Stroke; 2012 Oct; 43(10):2748-56. PubMed ID: 22933585
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
17. Src activates HIF-1α not through direct phosphorylation of HIF-1α specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase/Rac pathway.
Lee HY; Lee T; Lee N; Yang EG; Lee C; Lee J; Moon EY; Ha J; Park H
Carcinogenesis; 2011 May; 32(5):703-12. PubMed ID: 21335603
[TBL] [Abstract][Full Text] [Related]
18. A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.
Percy MJ; Furlow PW; Beer PA; Lappin TR; McMullin MF; Lee FS
Blood; 2007 Sep; 110(6):2193-6. PubMed ID: 17579185
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization and mRNA expression of HIF-prolyl hydroxylase-2 (phd2) in hypoxia-sensing pathways from Megalobrama amblycephala.
Wang H; Huang C; Chen N; Zhu K; Chen B; Wang W; Wang H
Comp Biochem Physiol B Biochem Mol Biol; 2015 Aug; 186():28-35. PubMed ID: 25868626
[TBL] [Abstract][Full Text] [Related]
20. miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.
Jiao X; Xu X; Fang Y; Zhang H; Liang M; Teng J; Ding X
Nephrology (Carlton); 2017 May; 22(5):366-373. PubMed ID: 27030384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
